What we are studying
The purpose of this research study is to determine whether during this period of time, giving an antibody in the form of a medication called Durvalumab (study drug) can hold the tumor from growing and to examine the effect of this study drug against cancer. Antibodies are proteins produced by the defense system of the body (immune system) that have been made in the laboratory. This treatment helps increase the activity of the immune system that in many cases is decreased by the cancer. When the immune system is more active, it has a better chance to fight the cancer in the body, trying to limit the spread of the cancer. This medication is considered experimental for the treatment of SCCHN as it has not been yet approved by FDA.
Parking will be validated for study-related visits